Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation…
Subpotent
Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error…
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
Lack of assurance of sterility.
Lack of assurance of sterility.
Lack of assurance of sterility.
Lack of Assurance of Sterility: Leaking/damaged syringes.
Presence of Particulate Matter
Lack of Assurance of Sterility: Leaking/damaged syringes.
CGMP Deviations
Lack of Assurance of Sterility: Leaking/damaged syringes.
Lack of Assurance of Sterility: Leaking/damaged syringes.
Lack of Assurance of Sterility: Leaking/damaged syringes.
CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.
CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-desmethyl-diphenhydramine (n-dph), above the FDA…
CGMP Deviations
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Lack of Assurance of Sterility: Media fill with bacterial contamination